| Literature DB >> 34385846 |
Chengcheng Sheng1, Ying Wang1, Zongxu Xu1, Jun Wang1.
Abstract
PURPOSE: Previous studies indicated that the serum triglyceride level in patients with acute pancreatitis positively correlated with the severity of the disease among the general population. Despite the physiological hypertriglyceridemia in pregnant women, there are no reports on the relationship between serum triglyceride level and the severity of acute pancreatitis in pregnant (APIP) women. This study explores the relationship between serum triglyceride levels and the severity of APIP. PATIENTS AND METHODS: Clinical information of APIP patients admitted to the Shengjing Affiliated Hospital of China Medical University was gathered from January 2012 to December 2020 to conduct retrospective research. The participating patients were divided into mild, moderately severe, and severe acute pancreatitis. The clinical outcomes of patients with different serum triglyceride levels (0-2.3 mmol/L, 2.23-5.65 mmol/L, 5.65-11.2 mmol/l, ≥11.2 mmol/L) were analyzed by performing ordinal logistic regression analysis. Receiver operating curve analysis was used to calculate the threshold value of serum triglyceride concentration that can effectively predict the occurrence of severe acute pancreatitis (SAP).Entities:
Keywords: acute pancreatitis; gestation; hypertriglyceridemia; organ failure
Year: 2021 PMID: 34385846 PMCID: PMC8352647 DOI: 10.2147/RMHP.S318879
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Figure 1The selection process for patients in a flow chart.
Situation Analysis of Maternal Deaths
| Gestational Age, Weeks (n=81) | Etiology of AP | Cause of Maternal Death | TG Level at Admission, mmol/L | Fetal Outcomes | |
|---|---|---|---|---|---|
| Case 1 | 34 | HTG | MOF | 46 | Fetal death in the uterus |
| Case 2 | 23 | HTG | MOF | 10.54 | Abortion |
| Case 3 | 25 | HTG | Encephalopathy | 36.35 | Abortion |
| Case 4 | 33 | HTG | Cardiac sudden death | 35.22 | Fetal death in the uterus |
| Case 5 | 34 | HTG | MOF | 41.3 | Fetal death in the uterus |
| Case 6 | 32 | HTG | Cardiac sudden death | 88.4 | Premature birth |
| Case 7 | 30 | HTG | Hemorrhagic shock | 45.86 | Fetal death in the uterus |
Abbreviations: HTG, hypertriglyceridemia; MOF, multiple organ failure; TG, triglycerides.
Figure 2Comparison of serum amylase levels under different etiological factors. P=0.079.
Figure 3Comparison of serum lipase levels distribution under different etiological factors. P=0.026.
Comparison of General Conditions in Acute Pancreatitis Patients with Different Severity of Pregnancy
| MAP (n=92) | MSAP (n=65) | SAP (n=43) | ||
|---|---|---|---|---|
| Age, years, mean±SD | 27.52±4.75 | 29.89±5.24 | 30.65±5.10 | 0.001# |
| Trimester of pregnancy, n (%) | ||||
| First (before 14 weeks) | 10 (10.9%) | 1 (1.5%) | 1 (2.3%) | 0.132 |
| Second (14–27+6 weeks) | 14 (15.2%) | 11 (16.9%) | 9 (20.5%) | |
| Third (after 28 weeks) | 68 (73.9%) | 53 (81.5%) | 33 (76.7%) | |
| *Gravidity | 2 (1–3) | 2 (1–3) | 2 (1–3) | 0.384 |
| Parity | ||||
| 0 | 65 (75.3%) | 31 (47.7%) | 26 (60.5%) | 0.008# |
| 1 | 21 (23.6%) | 30 (46.2%) | 16 (37.2%) | |
| 2 times or more | 1 (1.1%) | 4 (6.2%) | 1 (2.3%) | |
| *BMI | 27.22 (23.88–28.93) | 27.61 (24.73–31.25) | 27.39 (23.66–31.25) | 0.417 |
| Diabetes, n (%) | ||||
| Diabetes in pregnancy | 2 (2.2%) | 2 (3.1%) | 1 (2.3%) | 0.061 |
| Gestational diabetes | 22 (23.9%) | 22 (33.8%) | 17 (39.5%) | |
| Hypertensive disorders, n (%) | ||||
| Gestational hypertension | 4 (4.3%) | 8 (12.3%) | 5 (11.6%) | 0.081 |
| Preeclampsia | 3 (3.3%) | 5 (7.7%) | 4 (9.3%) | |
| Eclampsia | 1 (1.1%) | 2 (3.1%) | 0 (0.0%) | |
| Etiology, n (%) | ||||
| Biliary | 29 (31.5%) | 9 (13.8%) | 2 (4.7%) | <0.05# |
| HTG | 20 (21.7%) | 42 (64.6%) | 32 (74.4%) | |
| Idiopathic | 43 (46.7%) | 14 (21.5%) | 9 (20.9%) |
Notes: *Indicates that data were not normally distributed and were expressed as median (interquartile range), M(Q); #Indicates P<0.05, indicating that the difference was statistically significant.
Abbreviations: BMI, body mass index; HTG, hypertriglyceridemia; MAP, mild acute pancreatitis; MSAP, moderately severe acute pancreatitis; SAP, severe acute pancreatitis.
Comparison of Blood Lipids Levels Within 24 Hours After Admission in APIP Patients with Different Severity
| MAP (n=92) | MSAP (n=65) | SAP (n=43) | ||
|---|---|---|---|---|
| *TG, mmol/L | 3.08 (1.82–7.97) | 17.8 (4.30–40.17) | 24.98 (6.49–45.00) | <0.05# |
| *TC, mmol/L | 5.30 (4.24–7.03) | 11.62 (5.51–18.17) | 15.62 (6.01–20.69) | <0.05# |
| *HDL, mmol/L | 1.34 (0.97–1.66) | 1.37 (1.02–1.77) | 1.24 (0.79–1.68) | 0.682 |
| *LDL, mmol/L | 2.43 (1.73–3.37) | 2.29 (1.55–4.02) | 1.79 (1.14–3.38) | 0.234 |
| APO-A, g/L,mean±SD | 1.61±0.58 | 1.35±0.54 | 1.12±0.62 | <0.05# |
| APO-B, g/L,mean±SD | 1.09±0.39 | 1.03±0.57 | 0.88±0.62 | 0.062 |
Notes: *Indicates that data were not normally distributed and are expressed as median (interquartile range), M(Q); #Indicates P<0.05, indicating that the difference was statistically significant.
Abbreviations: APO, apolipoprotein; HDL, high density lipoprotein; LDL, low density lipoprotein; MAP, mild acute pancreatitis; MSAP, moderately severe acute pancreatitis; SAP, severe acute pancreatitis; TC, total cholesterol; TG, triglycerides.
Correlation Coefficients Between the Statistically Significant Indicators in Tables 1 and 2 and the Severity of Disease in APIP Patients
| Age, Years | TG, mmol/L | TC, mmol/L | APO-A, g/L | Parity,n | |
|---|---|---|---|---|---|
| <0.05# | <0.05# | <0.05# | <0.05# | 0.011 | |
| Correlation coefficient, | 0.255 | 0.489 | 0.403 | −0.322 | 0.169 |
Notes:#Indicates P<0.05, indicating that the difference was statistically significant.
Abbreviations: APO, apolipoprotein; TC, total cholesterol; TG, triglycerides.
Comparison of Clinical Characteristics of APIP Patients with Different Triglyceride Levels
| TG< 2.3mmol/L | TG≥ 2.3mmol/L and < 5.65mmol/L | TG ≥ 5.65mmol/L and <11.2mmol/L | TG≥ 11.2mmol/L | ||
|---|---|---|---|---|---|
| n | 45 | 46 | 29 | 80 | |
| *BMI | 26.98 | 27.06 | 26.56 | 28.33 | 0.534 |
| *Length of ICU stay, days | 0 (0–3) | 2 (1–3) | 3 (1–6) | 4 (3–7) | <0.05# |
| *Total costs, ¥ | 27,626 | 27,477 | 54,945 | 77,907 | <0.05# |
| Maternal deaths, n (%) | 0 (0%) | 0 (0%) | 1 (3.4%) | 6 (7.5%) | 0.011# |
| Fetal loss, n (%) | 10 (22.2%) | 5 (10.9%) | 8 (27.6%) | 32 (40.0%) | 0.010# |
| OF, n(%) | |||||
| Respiratory failure | 4 (8.9%) | 4 (8.7%) | 6 (20.7%) | 31 (38.8%) | <0.05# |
| Renal failure | 5 (11.1%) | 6 (13.6%) | 5 (17.2%) | 11 (13.8%) | 0.667 |
| Circulatory failure | 3 (6.7%) | 3 (6.7%) | 4 (13.8%) | 20 (25.0%) | 0.001# |
| POF, n (%) | 5 (11.1%) | 3 (6.5%) | 7 (24.1%) | 28 (35.0%) | <0.05# |
| Pleural effusion, n (%) | 11 (24.4%) | 15 (32.6%) | 16 (55.2%) | 47 (58.8%) | <0.05# |
| Peritoneal effusion, n (%) | 15 (33.3%) | 17 (37.8%) | 17 (58.6%) | 42 (52.5%) | 0.013# |
| Pelvic effusion, n (%) | 7 (16.3%) | 8 (17.4%) | 10 (34.5%) | 27 –(34.2%) | 0.008# |
| SIRS, n (%) | 15 (33.3%) | 13 (28.3%) | 12 (41.4%) | 48 (60%) | 0.009# |
| DKA, n (%) | 1 (2.2%) | 1 (2.2%) | 3 (10.3%) | 15 (18.75%) | 0.001# |
| Localized complications, n (%) | |||||
| Acute peri-pancreatic fluid | 10 (22.2%) | 13 (28.3%) | 7 (24.1%) | 33 (41.3%) | 0.004# |
| Pseudocyst | 2 (4.4%) | 4 (8.7%) | 2 (6.9%) | 4 (5.0%) | |
| Walled-off necrosis | 0 (0%) | 0 (0%) | 0 (0%) | 2 (2.5%) | |
| Acute necrotic collections | 0 (0%) | 1 (2.2%) | 1 (3.4%) | 3 (3.6%) |
Notes: *Indicates that data were not normally distributed and are expressed as median (interquartile range), M(Q); #Indicates P<0.05, indicating that the difference was statistically significant.
Abbreviations: BMI, body mass index; DKA, diabetic ketoacidosis; MAP, mild acute pancreatitis; MSAP, moderately severe acute pancreatitis; OF, organ failure; POF, persistent organ failure; SAP, severe acute pancreatitis; SIRS, systemic inflammatory response syndrome; TG, triglycerides.
Logistic Regression Analysis of the Relationship Between Triglyceride Level and Severity of APIP
| Model Adjustment | TG Classification | SE | Wald | OR (95% CI) | |
|---|---|---|---|---|---|
| Univariate Analysis | <2.3mmol/L | – | – | – | – |
| 2.3mmol/L~ | 0.463 | 0.52 | 0.819 | 1.112 (0.449–2.753) | |
| 5.65mmol/L~ | 0.494 | 6.814 | 0.009 | 3.631 (1.379–9.561) | |
| 11.2mmol/L~ | 0.410 | 29.818 | <0.05# | 9.365 (4.196–20.904) | |
| Adjust Modela | <2.3mmol/L | – | – | – | – |
| 2.3mmol/L~ | 0.484 | 0.005 | 0.941 | 1.036 (0.401–2.677) | |
| 5.65mmol/L~ | 0.507 | 5.905 | 0.015 | 3.429 (1.269–9265) | |
| 11.2mmol/L~ | 0.412 | 26.450 | <0.05# | 8.329 (3.713–18.682) |
Notes: Adjust Modela: adjusted for baseline age, Cholesterol, APO-A and parity; #Indicates P<0.05, indicating that the difference was statistically significant.
Abbreviations: ORs, odds ratios; TG, triglycerides;.
Figure 4Observed and expected incidence of SAP in patients with different triglycerides concentrations.
Figure 5Receiving operator curve of serum TG 24h within admission in predicting SAP.
Receiver Operating Characteristic Curve Analysis of the Predictors of SAP
| AUC (95% CI) | Sensitivity | Specificity | Threshold Value | ||
|---|---|---|---|---|---|
| TG, mmol/L | 0.708 (0.620–0.796) | <0.05 | 0.72 | 0.65 | 10.7 |
Abbreviations: AUC, area under curve; TG, triglycerides.